ClearPoint Neuro (CLPT) Tops Q3 EPS by 5c; Offers FY23 Revenue Guidance

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $6.73 million.

GUIDANCE:

ClearPoint Neuro, Inc. sees FY2023 revenue of $23-25 million, versus the consensus of $25.9 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance